Neogenomics, Inc.
NEO
$6.45
-$0.155-2.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -32.46% | 7.89% | 10.51% | 19.31% | 31.50% |
| Total Depreciation and Amortization | -2.34% | -1.38% | -0.05% | 0.60% | 1.74% |
| Total Amortization of Deferred Charges | -6.91% | 1.32% | 1.32% | 1.26% | 1.33% |
| Total Other Non-Cash Items | 62.83% | 17.47% | 19.05% | 21.75% | 20.41% |
| Change in Net Operating Assets | 40.17% | 23.05% | -28.00% | 32.23% | -35.20% |
| Cash from Operations | 5,221.59% | 150.15% | 459.60% | 164.07% | 100.77% |
| Capital Expenditure | -10.76% | -63.77% | -42.81% | -39.23% | -0.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -72.76% | -54.44% | -48.87% | -14.93% | 42.10% |
| Cash from Investing | -124.62% | -97.20% | -83.24% | -39.23% | 79.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2,236,011.11% | -- | -- | 96.61% | 96.33% |
| Issuance of Common Stock | -5.25% | -6.70% | -17.01% | -21.63% | -25.45% |
| Repurchase of Common Stock | -16.30% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -520.41% | 96.38% | 96.38% | 146.61% | 146.61% |
| Cash from Financing | -3,487.41% | 19.74% | 2.02% | 2.81% | -5.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -403.53% | -74.64% | -69.08% | 38.99% | 1,114.11% |